The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies

ABSTRACT: MAPPYACTS (NCT02613962) is an international prospective precision medicine trial aiming to define tumor molecular profiles in pediatric patients with recurrent/refractory malignancies in order to suggest the most adapted salvage treatment. From February 2016 to July 2020, 787 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Berlanga, Pablo, Pierron, Gaelle, Lacroix, Ludovic, Chicard, Mathieu, Adam de Beaumais, Tiphaine, Marchais, Antonin, Harttrampf, Anne C., Iddir, Yasmine, Larive, Alicia, Soriano Fernandez, Aroa, Hezam, Imene, Chevassus, Cecile, Bernard, Virginie, Cotteret, Sophie, Scoazec, Jean-Yves, Gauthier, Arnaud, Abbou, Samuel, Corradini, Nadege, André, Nicolas, Aerts, Isabelle, Thebaud, Estelle, Casanova, Michela, Owens, Cormac, Hladun-Alvaro, Raquel, Michiels, Stefan, Delattre, Olivier, Vassal, Gilles, Schleiermacher, Gudrun, Geoerger, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394403/
https://www.ncbi.nlm.nih.gov/pubmed/35292802
http://dx.doi.org/10.1158/2159-8290.CD-21-1136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394403/
https://www.ncbi.nlm.nih.gov/pubmed/35292802
http://dx.doi.org/10.1158/2159-8290.CD-21-1136

Ejemplares similares